U.S. commercial real estate entered the fourth quarter with stronger deal flow and improving operating data in several property types. But the rebound in reported sales overstates the breadth of liquidity, and the cost of capital remains the binding constraint for many refinancings.
Executive assessment. Q3 marked a material improvement in transaction activity, but not a broad-based reset in values or credit availability. MSCI recorded $263.7 billion of U.S. CRE sales, up 89% year over year; $142.8 billion was portfolio or entity-level activity. That is 54% of reported volume (Sterling calculation: $142.8bn ÷ $263.7bn). Industrial, apartments and data centers led dollar volume. Office sales grew from a depressed base while leasing remained highly selective. Meanwhile, 10-year Treasury yields ended September at 5.29% and were still 5.15% on November 13, above June’s 4.44%. Debt is available, but proceeds, debt-service coverage and refinancing equity remain property-specific.
Q3 2026; +89% year over year. Portfolio/entity trades were 54% of volume.
November 13, 2026; down 14 bps from September 30, up 71 bps from June 30.
CMBS 30+ day delinquency rate, Q3 2026; up from 4.82% in Q2.
Quarter in context
Observed The economy remained expansionary. BEA’s October 29 advance estimate put Q3 real GDP growth at 3.4% annualized, following 2.2% in Q2. BLS reported October payroll growth of 165,000 and unemployment of 4.1% on November 6. October CPI rose 0.4% month over month; shelter rose 0.3%. BLS did not publish 12-month CPI changes in that release, so this brief does not infer annual inflation from the monthly print.
Observed The Federal Reserve held its target range at 3.75%–4.00% on October 28, after a 25 bp reduction on September 17. Long rates moved differently from the policy rate: the 10-year Treasury rose from 4.44% on June 30 to 5.29% on September 30, then eased to 5.15% by November 13. This divergence matters to CRE because longer fixed-rate borrowing costs do not move one-for-one with the overnight policy rate.
Long yields stayed high after quarter-end
U.S. Treasury constant-maturity 10-year yield, percent. Observed daily rates, not a forecast.
Interpretation Economic growth and positive operating metrics help tenant demand and property income. At the same time, inflation uncertainty and the long end of the Treasury curve limit the benefit of lower short rates. Valuation sensitivity remains greatest where cash flows are not yet stabilized or refinancing relies on cap-rate compression.
Capital markets and refinancing
Observed MSCI’s October 29 report put Q3 transaction volume at $263.7bn, +89% year over year. CBRE reported $257.8bn, +98%, and attributed much of the jump to two entity-level deals totaling $104bn. These estimates use different provider datasets and should not be combined. MSCI’s $142.8bn in portfolio and entity transactions represented 54% of its total; single-asset volume was $120.9bn, up 6%. Activity recovered, but the single-asset market was far less dynamic than the headline suggests.
Reported Q3 sales skewed to apartments and industrial
MSCI Q3 2026 U.S. transaction volume by selected property type, $ billions. Asset-type totals need not sum to total CRE volume because classifications and special sectors vary.
Observed CBRE’s Q3 lending survey showed commercial mortgage loan spreads tightened 23 bps year over year to 197 bps for fixed 5–10-year permanent loans, while average mortgage rates rose to 6.0% from 5.8%. Average commercial LTV fell to 64.3% from 66.9%; debt-service coverage was 1.32x versus 1.34x. Alternative lenders accounted for 48% of non-agency closings, banks 26%, life companies 20%, and CMBS 6%. The mix signals available credit, but also continued lender selectivity and larger roles for non-bank capital.
Observed MBA’s Q3 survey found CMBS 30+ day delinquency at 4.97%, up from 4.82% in Q2; life company delinquency was 1.33%, GSE 1.16%, and FHA 0.90%. MBA covers a large but incomplete share of mortgage debt and these loan-type series are not directly comparable with broader special-servicing or property-level distress measures.
Observed Newmark reported debt originations up 20% year over year through Q3. Yet, for rolling 12-month refinancing volume, appraised values were below prior loan origination values for 26% of office and 41% of retail loans. This measure indicates potential equity gaps; it does not establish default or loss severity.
Underwriting implication Size refinancing at current lender quotes and in-place cash flow. Model debt yield, amortization, reserves and required equity explicitly; stress rates, NOI and exit capitalization independently. Treat a loan extension as a negotiated outcome with conditions, not as base-case capital.
Property markets
National indicators below come from named research providers and carry provider-specific definitions. Market-level comparisons should use consistent datasets; vacancy, availability and absorption are not interchangeable.
Office
Observed CBRE reported Q3 net absorption of 4.9 million sq. ft., a fifth consecutive quarterly decline in vacancy to 18.2%, and 63.8 million sq. ft. of leasing. Cushman & Wakefield’s separate series showed 19.8% vacancy and just 50,000 sq. ft. of quarterly net absorption. The difference reflects provider coverage and methodology; the shared message is that national vacancy remains high while recovery is uneven.
Positive annual absorption was concentrated in a limited group of markets. Cushman & Wakefield cited Midtown Manhattan (+6.5 msf), San Francisco (+3.5 msf), Orange County (+2.7 msf), Dallas (+2.4 msf), and San Jose (+2.3 msf) over four quarters. Prime, well-located, amenitized buildings have stronger leasing evidence than commodity assets. Underwrite tenant improvements, free rent, capital expenditures and lease-up duration property by property. Distressed office sales may offer basis, but demand and conversion feasibility remain asset-specific.
Multifamily
Observed Cushman & Wakefield reported national vacancy at 8.6% in Q3, down 30 bps sequentially, almost 350,000 units of absorption through nine months (+14% y/y), and 2.3% asking-rent growth. Deliveries fell 25% to about 250,000 units in the quarter. Its market data highlighted absorption of more than 50,000 units in Dallas–Fort Worth and 37,000 in New York City, with large supply pipelines still concentrated in Sun Belt markets.
Supply relief is not uniform: lease-up competition remains important in high-delivery metros, while the construction pipeline has contracted in most markets. CBRE and Cushman & Wakefield publish materially different multifamily vacancy and rent series; use one provider consistently for time-series underwriting. Favor submarkets where concessions, competing deliveries and attainable rents support the actual rent roll. Test taxes, insurance, payroll and turnover alongside rent growth.
Industrial
Observed CBRE reported 104.6 msf of Q3 net absorption, its strongest quarter since Q4 2022, and 276.8 msf of leasing, up 27.1% y/y. Vacancy was 6.4%, down 20 bps year over year; availability was 8.9%. Completions were 79.4 msf, below absorption, while 278 msf remained under construction. Year-to-date absorption leaders were Dallas–Fort Worth (23.6 msf), Houston (18.1 msf) and Atlanta (13.6 msf).
The supply-demand balance improved nationally, but active pipelines and tenant concentration create submarket risk. Stress rent spreads at rollover, tenant credit, downtime, tenant improvements and new deliveries. Functional modern logistics near population, ports and transport nodes merits a different risk view from older, shallow-bay or specialized buildings.
Retail
Observed CBRE recorded 9.6 msf of Q3 net absorption and 4.8% availability; asking rents rose 2.5% y/y to $24.89/sq. ft. Q3 investment volume fell 6% y/y to $16.8bn. Dallas led quarterly absorption with 924,000 sq. ft. New construction remained limited relative to prior cycles.
Low availability supports well-located neighborhood and necessity retail, but tenant health and lease rollover drive outcomes. Newmark’s refinancing analysis found retail appraisals below prior loan origination on 41% of rolling-12-month refinance volume. Underwrite tenant sales and credit, co-tenancy, recoveries, capital obligations and near-term maturities; do not extrapolate national rent gains across weaker centers.
Hospitality
Observed Cushman & Wakefield reported Q3 RevPAR growth of 7.1% y/y, with occupancy up 2.7% to 67.7% and ADR up 4.3% to $169. Washington, D.C. (+17.8%), Philadelphia (+17.5%) and Chicago (+15.6%) led major urban markets. Las Vegas fell 4.6%. The report attributed part of the D.C. and Philadelphia strength to America 250 events and expected moderation as those events fade. Rising operating expenses continued to pressure margins.
Recent revenue growth warrants scrutiny by day of week, source market and event calendar. Test wage, insurance, utilities and renovation costs; use normalized occupancy and ADR rather than extrapolating a single event-heavy quarter.
Specialty
Medical outpatient. CBRE reported Q3 absorption of 931,000 sq. ft. (+20% y/y), vacancy down 17 bps y/y to 9.7%, asking rents up 1.3% to $25.52/sq. ft., and investment sales up 13.4% y/y to $3.1bn. Completions were 264,000 sq. ft. Healthcare tenancy supports durable demand, but lease economics and provider credit remain central.
Life sciences. The market showed an early stabilization signal, not a full recovery. Cushman & Wakefield put vacancy at 23.9%, down 20 bps q/q for the first time in four years; absorption was nearly 500,000 sq. ft. and leasing rose 11% q/q to 2.9 msf. Asking rents still fell 5.6% y/y to $62.85/sq. ft.; 5.2 msf was under construction, down 40% y/y. CBRE’s separate series showed 23.4% vacancy and rents down 7.2% y/y. Funding and tenant credit, lab-ready condition, specialized systems and re-tenanting costs should govern basis.
Data centers. A Q3 U.S. market series was not available by the cutoff. Latest published CBRE H1 2026 North American data showed primary-market vacancy of 1.4%; Northern Virginia vacancy was 0.2%, with 2,420 MW under construction. More than 80% of the 7,481 MW under construction across eight primary markets was preleased. Power access, utility timelines, water, equipment procurement and tenant concentration are project-level constraints; H1 figures should not be presented as Q3 conditions.
Seniors housing and care. MSCI recorded $8.9bn of Q3 transactions, up 76% y/y. That is a capital-markets signal, not evidence of improving operating fundamentals. Staffing, occupancy, operator credit, regulatory compliance and care acuity require asset-specific diligence.
Devil’s advocate: the rebound may be mostly mechanical
The strongest countercase is that Q3 volume reflects a small number of very large entity transactions, easier year-over-year comparisons and motivated sellers meeting capital that had been sidelined. That does not prove broad repricing or a durable lending recovery. Single-asset volume in MSCI’s series was up only 6%. Long Treasury yields remained elevated, average mortgage rates rose despite tighter spreads, and the MBA delinquency trend worsened in CMBS. A slowing labor market or renewed rate rise could compress transaction liquidity again. Multifamily and industrial supply remains meaningful in select Sun Belt markets; office leasing gains are too concentrated to support generalized recovery claims. Hotel growth in event markets may fade, while lab vacancy and rents remain weak despite one quarter of improving absorption.
Confirmation indicators over the next two quarters: growth in single-asset transactions across property types; stable or falling 10-year Treasury yields; debt originations broadening beyond large portfolio and bridge loans; lower delinquency and special servicing; positive office absorption across more markets; continued industrial vacancy decline after deliveries; multifamily rent growth without elevated concessions; hotel occupancy gains outside event-led markets; and life-sciences vacancy falling with rent declines moderating.
Invalidation indicators: Treasury yields returning above Q3 highs and sustained mortgage-rate increases; widening lender spreads or falling proceeds; continued increase in CMBS delinquency; renewed negative office absorption; rising multifamily concessions and vacancy in high-delivery metros; industrial completions again exceeding absorption; hotel occupancy reversal; or life-sciences vacancy resuming its rise. A smaller share of portfolio trades without growth in single-asset sales would also challenge the liquidity thesis.
Investment and underwriting stance
| Decision area | Q3 evidence | Underwriting response |
|---|---|---|
| Acquisitions | Transaction activity returned, but portfolio/entity deals dominate the headline. | Require asset-level evidence of rent, occupancy, capex and financing. Do not mark comparable values up solely on sector volume. |
| Debt and refinance | Spreads tightened; base rates and average mortgage coupons remained high. Appraisal gaps persist, especially retail and office. | Model current lender proceeds and a no-extension case. Include interest reserves, amortization, equity cure and refinance costs in downside tests. |
| Office | National absorption improved, but vacancy remains high and market gains are concentrated. | Price lease-up, tenant improvements, concessions and capital needs explicitly. Prefer demonstrable tenant demand and a viable alternate-use case only where conversion economics are evidenced. |
| Multifamily / industrial | Demand outpaced current deliveries at the national level; supply remains concentrated by metro. | Use submarket delivery schedules, concessions, rent comparables and tenant rollover. Avoid extrapolating national absorption to assets in lease-up corridors. |
| Specialty | MOB demand was firmer; life sciences remains oversupplied; data centers face power and delivery constraints. | For MOB, test provider credit and reimbursement exposure. For labs, demand and conversion costs. For data centers, contracted power and construction milestones before applying stabilized value. |
Practical stance: pursue basis-sensitive, cash-flow-led opportunities where current debt is supportable and downside liquidity is funded. Keep terminal cap rates and exit timing conservative. Treat lender extensions, rate relief and operating recovery as scenarios rather than entitlements.
Data coverage and method
This brief covers the quarter ended September 30, 2026, with data available through November 15, 2026. Q4 2026 has not concluded. Some Q3 market datasets were published only in October or November; this brief uses their latest published quarter and labels later monthly or H1 observations separately. There was no published Q3 U.S. data center market series in the sources reviewed by the cutoff; H1 2026 is the latest cited national data. National property indicators vary by provider universe and definition, particularly multifamily and office. Provider data are shown with attribution and not blended. Figures labeled “calculation” are arithmetic from sourced reported values. Scenarios and underwriting responses are analytical judgments, not provider forecasts. No unsupported assumption about Sterling’s portfolio, strategy, leverage or geography is made.
Sources
- MSCI, Real Estate in Focus: U.S., October 29, 2026. Q3 transaction volume by asset type and deal structure.
- CBRE, Q3 2026 capital markets report / U.S. Quarterly Figures, November 2026. Capital markets volume, entity-level deals and debt conditions.
- CBRE, Commercial Real Estate Lending Reflects a Market in Transition in Q3 2026, November 9, 2026.
- Newmark, 3Q26 U.S. Capital Markets Conditions & Trends, November 2026.
- Mortgage Bankers Association, Commercial/Multifamily Mortgage Delinquencies Increased in Third Quarter of 2026, October 27, 2026.
- U.S. Treasury, Daily Treasury Par Yield Curve Rates, observations June 30, September 30 and November 13, 2026.
- Federal Reserve, FOMC calendars and statements, September 17 and October 28, 2026.
- BEA, GDP (Advance Estimate), 3rd Quarter 2026, October 29, 2026.
- BLS, Employment Situation — October 2026, November 6, 2026.
- BLS, Consumer Price Index — October 2026, November 10, 2026.
- CBRE, Q3 2026 U.S. Office Market Report, October 2026; and Cushman & Wakefield, U.S. Office MarketBeat, Q3 2026.
- Cushman & Wakefield, Q3 2026 U.S. Multifamily MarketBeat, October 2026.
- CBRE, Q3 2026 U.S. Industrial & Logistics Market Report, October 2026.
- CBRE, Q3 2026 U.S. Retail Market Report, November 3, 2026.
- Cushman & Wakefield, Q3 2026 U.S. Hospitality MarketBeat, November 12, 2026.
- CBRE, Q3 2026 U.S. Medical Outpatient Buildings Market Report, November 5, 2026.
- Cushman & Wakefield, Q3 2026 U.S. Life Sciences MarketBeat, November 13, 2026; and CBRE, Q3 2026 U.S. Life Sciences Lab/R&D Market Report, October 29, 2026.
- CBRE, North American Data Center Trends, H1 2026, September 8, 2026.

